neurotransmission operates on a millisecond timescale but is changed by normal experience or neuropathology over days to months. despite the importance of long-term neurotransmitter dynamics, no technique exists to track these changes in a subject from day to day over extended periods of time. here we describe and characterize a microsensor that can detect the neurotransmitter dopamine with subsecond temporal resolution over months in vivo in rats and mice.
is used to detect subsecond changes in behaviorally evoked dopamine release after the presentation of salient stimuli and during behavioral tasks [6] [7] [8] . However, existing approaches are constrained by the requirement for acute implantation of a voltammetric probe into the brain via a microdrive for each experiment 9 , limiting the ability to track longitudinal changes in neurotransmitter dynamics over the course of disease progression in animal models or throughout most learning paradigms 10 . Conversely, previous attempts to use chronically implanted electrodes to make long-term electrochemical measurements have had limited success [11] [12] [13] . These studies conclude that the fidelity of chemical recordings can be severely impaired by perturbation of the microenvironment through physical tissue disruption and/or neuroinflammation, emphasizing that size and biocompatibility are critical considerations in the design of chronic devices for in situ neurochemistry 14, 15 .
Here we describe a biocompatible voltammetric microsensor that can be chronically implanted into the targets of midbrain dopamine systems where it can detect subsecond dopamine dynamics from day to day over periods of months. This microsensor consists of a 7-µm-diameter carbon fiber housed in a 90-µmdiameter polyimide-covered fused-silica capillary (Fig. 1a) . These microsensors produced a linear response to physiological concentrations of dopamine as assessed in vitro with flow-injection analysis (n = 5, r 2 = 0.92, P < 0.0001; Fig. 1b) .
To determine the biocompatibility and suitability for long-term chemical recordings, we assessed the expression of glial markers and tyrosine hydroxylase using immunohistochemistry after chronic microsensor implantation. We prepared striatal slices from rats implanted with microsensors for 10-16 weeks and
The mesencephalic dopamine systems are a primary focus of research into motor control, motivation and reinforcement learning 1, 2 , and their disruption is implicated in many neurological and neuropsychiatric disorders, including Parkinson's disease, schizophrenia, substance abuse and depression 3, 4 . In particular, much attention focuses on the subsecond electrophysiological responses of dopamine neurons to behaviorally relevant stimuli including primary rewards, reward-predicting cues and new objects 1 . Consequently, the detailed characterization of the activity of dopamine neurons and ensuing dopamine release in target structures has been and continues to be a highly active and important area of research.
Chemical approaches are necessary to directly assess extracellular dopamine dynamics in target structures 5 . Classic neurochemical techniques, such as microdialysis, are ideal for measuring tonic baseline levels of neurotransmitters such as dopamine but have low sampling rates (minutes) and thus cannot temporally resolve the rapid changes in extracellular dopamine concentration predicted by neurophysiological data. However, electrochemical techniques, such as fast-scan cyclic voltammetry (FSCV), can provide the necessary high temporal resolution detection. FSCV offers chemical selectivity to discriminate dopamine from other electroactive species in the brain by providing an electrochemical signature (cyclic voltammogram) of the analyte. This methodology a b stained the slices for markers of microglia (Iba1) and astrocytes (glial fibrillary acidic protein; GFAP). We detected dopamine in vivo at four of the five implantation sites tested. We found no glial encapsulation near the tract left by the 7-µm carbon fiber ( Fig. 2a) in agreement with previous studies demonstrating that probes less than 12 µm in diameter are not encapsulated 15 . In some slices, we detected a few reactive astrocytes near the fused-silica shaft, as indicated by an increase in GFAP staining ( Supplementary Fig. 1) , and a small number of dispersed activated microglia, as evident by their condensed morphology. However, even around the tract left by the shaft, glial encapsulation was not evident. In comparison to control tissue, we found that tyrosine hydroxylase immunostaining was decreased along the tract left by the fused silica shaft but not at the site of the carbon fiber ( Fig. 2a and Supplementary Fig. 1 ). No differences in gliosis or tyrosine hydroxylase staining were noted between the implantation sites of the four functional microsensors and that of the single microsensor that did not detect dopamine. Lack of dopamine detection in apparently healthy tissue is not surprising given previous findings demonstrating the heterogeneity in behaviorally evoked dopamine signals in the striatum 16 . Together, these results demonstrate that chronic implantation of the carbon fiber for up to 4 months did not result in overt reactive gliosis, encapsulation of the carbon fiber or a loss of tyrosine hydroxylase expression, any of which could affect chemical detection.
To determine the stability of microsensor sensitivity during implantation, we extracted electrodes from 14 rats after 1-4 months in the brain and tested microsensor sensitivity to dopamine in the flow-injection apparatus in vitro. Dopamine sensitivity was not significantly different between microsensors that had been implanted for 1, 2 or 4 months (F 2,11 = 0.012, P = 0.99; Fig. 2b) and was similar to that for microsensors that had not previously been implanted ( Fig. 1b) indicating stability during chronic implantation for up to 4 months.
Next we tested the ability of the chronically implanted microsensor to detect dopamine in vivo. The functionality of a voltammetry electrode can be assessed by measuring fluctuations in dopamine release after electrical stimulation of the ventral tegmental area (VTA), substantia nigra pars compacta or the medial forebrain bundle 6 . Using the chronically implanted microsensor, we detected electrically evoked dopamine release in the nucleus accumbens, and it was comparable to that obtained with acute voltammetry electrodes in this work ( Fig. 2c ) and in previous reports 6 . FSCV is known to confer temporal distortion to in vivo dopamine signals 17 . However, we noted that there was more temporal distortion in the response from the chronically implanted microsensor compared to an acutely implanted electrode ( Supplementary Fig. 2 ). Although this process does not impair the detection of changes in phasic signaling amplitude during learning or in disease models, mathematical deconvolution procedures may be useful for quantitatively precise kinetic analysis 17 .
Electrically evoked neurochemical signals provide a reliable means to assess the functionality of specific recording electrodes, but behaviorally evoked signals, such as reward presentation, are often more experimentally relevant. Delivery of natural rewards has been shown to increase the firing of dopamine neurons in the VTA and substantia nigra pars compacta in monkeys 1 and elicits dopamine release in the nucleus accumbens in rats 7 . The chronic microsensor was also effective at detecting dopamine release to this type of stimulus (Fig. 2c) . The cyclic voltammogram corresponding to the food-evoked signal was significantly correlated with an electrically evoked signal from the same microsensor (r 2 ≥ 0.75, P < 0.0001; Fig. 2c ), indicating that the behaviorally evoked signal is reliably identified as dopamine by established signal identification methods (cyclic voltammogram analysis). In addition, a comparison of cyclic voltammograms obtained in vitro and under a variety of conditions in vivo revealed a significant correlation for all observations (r 2 ≥ 0.75, P < 0.0001; Supplementary  Fig. 3) . This relationship was similar to that for acute electrode preparations (Supplementary Fig. 3) . The behaviorally evoked signal could be attenuated by inactivation of the VTA, the primary dopamine innervation to the nucleus accumbens, thus validating the signal (Supplementary Fig. 4 ). Collectively this electrochemical and pharmacological characterization together with the anatomical, physiological and independent verification (Supplementary Note) provides a high degree of confidence that the recorded signal is that of dopamine.
To assess the longevity of dopamine detection with this approach, we chronically implanted 20 microsensors and repeatedly tested their ability to detect behaviorally evoked dopamine release, verified by cyclic voltammogram analysis (Fig. 3a) . There are several potential sources of electrode attrition relevant to maintaining chronic recordings; therefore, we included all electrodes in the analysis regardless of their failure mode ( Supplementary  Table 1 ). Four microsensors failed before dopamine detection. The remaining 16 microsensors could detect dopamine for 1.5-4 months after surgery.
We reliably detected behaviorally evoked dopamine release in the nucleus accumbens 1, 2 and 4 months after implantation (Fig. 3b) . Cyclic voltammograms obtained from reward-evoked dopamine release at these time points and those obtained from electrically evoked release at 1 and 2 months after surgery were significantly correlated with each other and those obtained in vitro (r 2 ≥ 0.75, P < 0.0001; Supplementary Table 2 ). This maintained fidelity in vivo is consistent with the demonstration that microsensor sensitivity is stable over months after implantation. Finally, we monitored electrochemical signals during multipleday reinforcement learning to demonstrate the potential of combining a chronically implantable microsensor with FSCV in assessing the dynamics of phasic dopamine release events over time. A specific role for dopamine in reinforcement learning is suggested by data from numerous paradigms 2 . Indeed, previous work with FSCV has demonstrated phasic dopamine release events in response to primary rewards and their predictors 8 . However, a complete characterization of phasic dopamine events in response to conditioned and unconditioned stimuli throughout learning has remained elusive because of methodological constraints 10 , which can be overcome by our approach. We plotted fluctuations in dopamine concentration recorded in the nucleus accumbens by the chronic microsensor during every trial during 25 d of training on a Pavlovian conditioned approach task in a representative rat (Fig. 3c) . These data illustrate the trial-by-trial shift in phasic dopamine responses from reward presentation to a predictive cue during acquisition (days 1-5) and a persistent cue response during extended training (days 6-10). The capacity to sample from the same subject throughout all behavioral manipulations reveals the modulation of reward-evoked responses by changes in reward value (increased reward days [16] [17] [18] [19] [20] and the attenuation of cue-evoked responses during extinction (reward omission days 21-25).
The advantage of our approach is in the ability to obtain multiple, repeated recordings in a single subject over a period of days, weeks or months. In addition to the assessment of the neurochemical correlates of psychological processes such as learning and memory, research aimed at exploring dopamine in animal models of psychiatric or neurological disorders will benefit from the capacity to measure during all aspects of the modeled disorder 18, 19 . Although we collected the longitudinal data presented here in rats, we also used this microsensor for long-term, in vivo neurochemical measurements in mice (Supplementary Fig. 3) . The now widely used manipulation of the mouse genome makes this an attractive species for the study of disease processes. Finally, our approach also permits the simultaneous assessment of dopamine release in multiple brain nuclei in a single subject (Supplementary Fig. 5) , a manipulation not possible with currently available methodology. These additional applications have the potential to extend the already rich field of in vivo voltammetry and allow researchers to make new inquiries and approach long-standing questions in a new way.
methods
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturemethods/.
Note: Supplementary information is available on the Nature Methods website. online methods Microsensor fabrication. Dopamine microsensors for chronic implantation consisted of carbon-fiber microelectrodes insulated in a fused-silica capillary 20, 21 . A single carbon fiber (grade 34-700; Goodfellow Corporation) was inserted into a 10-15-mm length of fused silica (Polymicro Technologies) while submerged in 2-propanol. One end of the microsensor was then sealed with Devcon two-component epoxy (IWT Performance Polymers) and allowed to dry, leaving a length of carbon fiber protruding. A silver connector was secured in contact with the carbon fiber on the other end of the silica with silver epoxy (MG Chemicals), allowed to cure overnight then insulated with a layer of two-component epoxy. After an additional 12 h of drying, the fabrication of the chronic microsensor was finalized by trimming the exposed carbon fiber to the desired length of the sensor (150-200 µm).
Electrochemical instrumentation. During voltammetric analysis, analyte electrolysis is driven by applying an electrical potential via an electrode, and chemical information is provided in the ensuing current, measured at the electrode. For all recordings, the applied potential to the microsensor was held at -0.4 V versus Ag/AgCl between voltammetric scans and then ramped to +1.3 V and back at 400 V s -1 during the scan (8.5 ms total scan time). Voltammetric scans were repeated every 100 ms to obtain a sampling rate of 10 Hz. When dopamine is present at the surface of the electrode during a voltammetric scan, it is oxidized during the anodic sweep to form dopamine-o-quinone (peak reaction at approximately +0.7 V) which is reduced back to dopamine in the cathodic sweep (peak reaction at approximately -0.3 V). The ensuing flux of electrons is measured as current and is directly proportional to the number of molecules that undergo the electrolysis. For the chemical identification of dopamine, current during a voltammetric scan can be plotted against the applied potential to yield a cyclic voltammogram. The cyclic voltammogram provides a chemical signature that is characteristic of the analyte, allowing resolution of dopamine from other substances. For quantification of changes in dopamine concentration over time, the current at its peak oxidation potential can be plotted for successive voltammetric scans. Waveform generation, data acquisition and analysis were carried out on a PC-based system using two multifunction data acquisition cards and software written in LabView (National Instruments). Signals were transmitted from chronically implanted microsensors to the data acquisition system via a head-mounted voltammetric amplifier (current-to-voltage converter) and an electrical swivel (Crist Instrument Co.) mounted above the recording chamber. The voltammetric amplifier consisted of an operational amplifier with a feedback resistor (R f ; 5 M), which determined the current-to-voltage 'gain' (following Ohm's law: V out = I in × R f ). In addition, a capacitor (6 pF) was connected in parallel with the feedback resistor to filter high frequencies, whereas other capacitors bridged each of the power sources (+15 V, -15 V) with ground to filter operational amplifier noise. As reported elsewhere 22 , there is commonly a 200 mV shift in the reference potential at implanted Ag/AgCl electrodes. This change can be diagnosed by the position of Faradaic peaks within the background current and, when observed, the applied potential was offset by 200 mV to compensate, as previously described 23 .
Assessment of electrode sensitivity. The sensitivity of the microsensor to dopamine was determined in vitro before and/or after 1, 2 and 4 months implantation in brain using flow injection analysis. Briefly, the microsensor was placed in a flowing stream of artificial cerebrospinal fluid (ACSF; 3 ml min -1 ) and electrochemical measurements were made with FSCV using the same parameters used for in vivo recordings. A time-dependent square pulse of dopamine (dissolved in ACSF) was introduced into the flow stream via an injection valve (Upchurch Scientific). The sensitivity of the microsensor was determined by dividing the change in the voltammetric signal during introduction of dopamine by its concentration.
Voltammetry surgery. All animal procedures presented in this paper followed the University of Washington Institutional Animal Care and Use Committee guidelines. Surgical preparation for in vivo voltammetry used aseptic technique. Male rats weighing 300-350 g (Charles River) were anesthetized with isoflurane and placed in a stereotaxic frame. The scalp was swabbed with 10% povidone iodine, bathed with a mixture of lidocaine (0.5 mg kg -1 ) and bupivicaine (0.5 mg kg -1 ), and incised to expose the cranium. Holes were drilled and cleared of dura mater above the nucleus accumbens core (1.3 mm lateral and 1.3 mm rostral from bregma), the dorsolateral striatum (4.3 mm lateral and 1.2 mm rostral from bregma) and/or the nucleus accumbens shell (0.8 mm lateral and 1.2 mm rostral from bregma) for microsensors, above the midbrain (1.0 mm lateral and 5.2 mm caudal from bregma) for a stimulating electrode in some rats, and at convenient locations for a reference electrode and three anchor screws. The reference electrode and anchor screws were positioned and secured with cranioplastic cement, leaving the stimulating electrode and working electrode holes exposed. The microsensors were then attached to the voltammetric amplifier and lowered into the target recording regions (7.0 mm ventral of dura mater for nucleus accumbens and 4.0 mm ventral of dura mater for dorsolateral striatum). For rats in which a stimulating electrode was implanted, the voltammetric waveform was applied at 10 Hz and dopamine monitored. Next, the stimulating electrode (Plastics One) was lowered 7.0 mm below dura mater and electrical stimulation (60 biphasic pulses, 60 Hz, ± 120 µA and 2 ms per phase) was applied via an optically isolated, constant-current stimulator (A-M Systems). If an evoked change in dopamine concentration was not observed at the working electrode, the stimulating electrode was positioned 0.2 mm more ventrally. This was repeated until dopamine efflux was detected after stimulation. The electrode was then lowered in 0.1-mm increments until dopamine release was maximal. This is usually when the stimulating electrode is 8.4 mm ventral from dura mater. Finally, cranioplastic cement was applied to the part of the cranium that is still exposed to secure the stimulating electrode and microsensor(s).
Recording sessions.
In vivo experiments were carried out in a standard operant chamber (Med Associates). A subset of rats was trained on a conditioned Pavlovian approach (autoshaping) task. Each trial in an autoshaping session consisted of an 8-s presentation of a lever or light cue (conditioned stimulus) followed immediately by the delivery of a food pellet (unconditioned stimulus). Each training session (one per day) was comprised of 25 trials presented on a 60-s variable-interval schedule. After 15 sessions of standard training, the reward value was increased from 1 to 4 food pellets for 5 d followed by 5 d of extinction training during which food reward was omitted.
